Stay updated on ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial
Sign up to get notified when there's something new on the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page.

Latest updates to the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page
- CheckyesterdayChange DetectedNew help and navigation items were added to guide users on eligibility, contact information, how to read a study record, common questions, and how to join a study. A label formatting update for Intervention/Treatment and a Revision notice to v3.6.0 were made, replacing the older v3.5.5.SummaryDifference0.2%

- Check8 days agoChange DetectedThe page revision tag was updated to Revision: v3.5.5, replacing the previous v3.5.4 label. This reflects a minor update to the page version without altering study content or outcomes.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe study record’s revision tag was updated from v3.5.3 to v3.5.4, indicating an administrative update to the entry. This update does not modify study details or eligibility criteria.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page’s footer shows a newer ClinicalTrials.gov site revision identifier (updated from v3.5.0 to v3.5.3). This reflects a platform/version update rather than a change to the study record itself.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded 'Carcinoma of esophagus' to the conditions list, a synonymous variation of Esophageal Carcinoma.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

Stay in the know with updates to ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page.